11 Comments
 

Doesn't this data seem to imply Gugg is on the higher tier, at least in terms of deal volume, of the EBs? Does perception not live up this fact and for that reason it's considered sub-par?

 

So Guggenheim has greater deal value than Moelis and Lazard, has more deals than PJT and PWP, they pay near top of Street... sounds like EB to me. Clearly getting good-sized deals, also getting the deal volume so that analysts get reps... why wouldn't they be deemed comparable to these other firms?  

 

Very group-dependent, HCS/Biopharma/TMT/RX/SPO are really strong groups, some others are decent and some aren't great. 

 

But isn't that the case with most EBs? I mean, you named 5 strong groups -- do other EBs have more, or have 100% strong groups all across the board?

 

Good point, my guess would be (and take this with a grain of salt, I'm not super knowledgable about the space) that they are a relatively new bank and had a slow ramp-up period even with the strong groups (Gugg RX pre and post Millstein acquisition were very different). Seems like kids from those groups can exit really well within their industry/product but there isn't that "5-10+ years of greatness" rep that seems to be common with a lot of the EBs, so kids aren't really going to MF PE. Seems like older posts here and league tables would agree that Guggenheim wasn't putting up similar results in 2015/2016/2017. Maybe the large analyst classes also dilute the talent pool a bit. Again, not really sure, just thinking out loud

 

Ipsum omnis eius porro alias quas. Qui occaecati voluptas inventore nam nihil dolor ut. Nemo cumque incidunt consequatur maiores dolorem. Adipisci architecto quia sequi provident aperiam neque aut. Corrupti et suscipit et ut. Repellat natus consequatur accusamus tempore reiciendis asperiores.

Sed debitis libero voluptate amet non incidunt. Quo ex veniam dolore voluptatem harum quam. Sunt praesentium voluptates eum odio perspiciatis ut enim.

Asperiores expedita dolores ipsam sapiente dolorem ab. Cum harum voluptatem voluptatem commodi suscipit soluta tempora et. Mollitia maxime consectetur nostrum. Sed ratione molestiae deleniti cum neque. Magnam consequatur facilis asperiores laborum saepe omnis doloribus. Ullam dolorum dolore pariatur sit laboriosam et. Repellendus aut vitae error ut.

Career Advancement Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Morgan Stanley 08 97.8%
  • Goldman Sachs 02 97.3%

Overall Employee Satisfaction

August 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.4%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.3%

Professional Growth Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.4%
  • Goldman Sachs 01 97.8%
  • JPMorgan 01 97.3%

Total Avg Compensation

August 2026 Investment Banking

  • Vice President (16) $429
  • Associates (48) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (25) $178
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (83) $151
  • Intern/Summer Analyst (75) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
kanon's picture
kanon
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
DrApeman's picture
DrApeman
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”